BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mahajan S, Choudhary S, Kumar P, Tomar S. Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens. Bioorg Med Chem 2021;46:116356. [PMID: 34416512 DOI: 10.1016/j.bmc.2021.116356] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Szczesniak I, Baliga-Gil A, Jarmolowicz A, Soszynska-Jozwiak M, Kierzek E. Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors. Int J Mol Sci 2023;24. [PMID: 36674746 DOI: 10.3390/ijms24021232] [Reference Citation Analysis]
2 Costa B, Vale N. Modulating Immune Response in Viral Infection for Quantitative Forecasts of Drug Efficacy. Pharmaceutics 2023;15. [PMID: 36678799 DOI: 10.3390/pharmaceutics15010167] [Reference Citation Analysis]
3 Balakrishnan AJ, Somasundaran AK, Janardhanan P, Pilankatta R. Peptides with antiviral activities. Antimicrobial Peptides 2023. [DOI: 10.1016/b978-0-323-85682-9.00002-7] [Reference Citation Analysis]
4 Nugrahani I, Susanti E, Adawiyah T, Santosa S, Laksana AN. Non-Covalent Reactions Supporting Antiviral Development. Molecules 2022;27. [PMID: 36558183 DOI: 10.3390/molecules27249051] [Reference Citation Analysis]
5 Robinson NA, Robledo D, Sveen L, Daniels RR, Krasnov A, Coates A, Jin YH, Barrett LT, Lillehammer M, Kettunen AH, Phillips BL, Dempster T, Doeschl‐wilson A, Samsing F, Difford G, Salisbury S, Gjerde B, Haugen J, Burgerhout E, Dagnachew BS, Kurian D, Fast MD, Rye M, Salazar M, Bron JE, Monaghan SJ, Jacq C, Birkett M, Browman HI, Skiftesvik AB, Fields DM, Selander E, Bui S, Sonesson A, Skugor S, Østbye TK, Houston RD. Applying genetic technologies to combat infectious diseases in aquaculture. Reviews in Aquaculture. [DOI: 10.1111/raq.12733] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Bhutkar M, Singh V, Dhaka P, Tomar S. Virus-host protein-protein interactions as molecular drug targets for arboviral infections. Front Virol 2022;2. [DOI: 10.3389/fviro.2022.959586] [Reference Citation Analysis]
7 LoMascolo NJ, Cruz-Pulido YE, Mounce BC. Bisacodyl Limits Chikungunya Virus Replication In Vitro and Is Broadly Antiviral. Antimicrob Agents Chemother 2022;:e0029222. [PMID: 35652314 DOI: 10.1128/aac.00292-22] [Reference Citation Analysis]
8 Režen T, Martins A, Mraz M, Zimic N, Rozman D, Moškon M. Integration of omics data to generate and analyse COVID-19 specific genome-scale metabolic models. Comput Biol Med 2022;145:105428. [PMID: 35339845 DOI: 10.1016/j.compbiomed.2022.105428] [Reference Citation Analysis]
9 Bhutkar M, Rani R, Kothiala A, Mahajan S, Waghmode B, Kumar R, Singh V, Sircar D, Kumar P, Tomar S. Elucidation of the antiviral mechanism of natural therapeutic molecules Herbacetin and Caffeic acid phenethyl ester against Chikungunya and Dengue virus.. [DOI: 10.1101/2022.05.31.494145] [Reference Citation Analysis]
10 Perrin-Cocon L, Kundlacz C, Jacquemin C, Hanoulle X, Aublin-Gex A, Figl M, Manteca J, André P, Vidalain PO, Lotteau V, Diaz O. Domain 2 of Hepatitis C Virus Protein NS5A Activates Glucokinase and Induces Lipogenesis in Hepatocytes. Int J Mol Sci 2022;23:919. [PMID: 35055105 DOI: 10.3390/ijms23020919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]